BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37643197)

  • 21. Nonmicroradical Resection Margin as a Predictor of Recurrence in Patients With Stage III Colon Cancer Undergoing Complete Mesocolic Excision: A Prospective Cohort Study.
    Gundestrup AK; Olsen ASF; Ingeholm P; Bols B; Kleif J; Bertelsen CA
    Dis Colon Rectum; 2022 May; 65(5):683-691. PubMed ID: 34933419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of the Tumor-Stroma Ratio and Structural Heterogeneity Measured by a Novel Semiautomatic Image Analysis Technique for Predicting Survival in Patients With Colon Cancer.
    Inoue H; Kudou M; Shiozaki A; Kosuga T; Shimizu H; Kiuchi J; Arita T; Konishi H; Komatsu S; Kuriu Y; Morinaga Y; Konishi E; Otsuji E
    Dis Colon Rectum; 2023 Nov; 66(11):1449-1461. PubMed ID: 36649165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study.
    Chang CY; Lin CC; Lin HH; Lan YT; Chang SC; Wang HS; Yang SH; Chen WS; Lin JK; Jiang JK
    Dis Colon Rectum; 2023 Oct; 66(10):e1032-e1042. PubMed ID: 36538674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and Prognostic Value of Lavage Cytology in Colorectal Cancer.
    Matsui S; Fukunaga Y; Sugiyama Y; Iwagami M; Nagasaki T; Akiyoshi T; Konishi T; Kawachi H
    Dis Colon Rectum; 2022 Jul; 65(7):894-900. PubMed ID: 34775412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediating Factors Between Race and Time to Treatment in Colorectal Cancer.
    Grunvald MW; Underhill JM; Skertich NJ; Williams MD; Aquina CT; Bhama AR; Hayden DM; Becerra AZ
    Dis Colon Rectum; 2023 Feb; 66(2):331-336. PubMed ID: 34933318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mid-transverse Location in Primary Colon Tumor: A Poor Prognostic Factor?
    Zenger S; Gurbuz B; Can U; Erginoz E; Ozata IH; Kulle CB; Balik E; Bugra D
    Dis Colon Rectum; 2022 Jun; 65(6):817-826. PubMed ID: 34039903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Impact of Extramural Lymphatic, Vascular, and Perineural Invasion in Stage II Colon Cancer: A Comparison With Intramural Invasion.
    Cho SS; Park JW; Kang GH; Kim JH; Bae JM; Han SW; Kim TY; Kim MJ; Ryoo SB; Jeong SY; Park KJ
    Dis Colon Rectum; 2023 Mar; 66(3):366-373. PubMed ID: 35333785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Work Ability in Patients With Stage I to IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort.
    Franken MD; Vink G; van Grevenstein WMU; Verkooijen HM; Punt CJA; Koopman M; May AM;
    Dis Colon Rectum; 2023 Jan; 66(1):50-58. PubMed ID: 34753892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of the Circumferential Resection Margin After Curative Surgery for Rectal Cancer: A Multicenter Propensity Score-Matched Analysis.
    Galvez A; Biondo S; Trenti L; Espin E; Kraft M; Farres R; Codina-Cazador A; Flor B; Garcia-Granero E; Enriquez-Navascues JM; Borda-Arrizabalaga N; Kreisler E
    Dis Colon Rectum; 2023 Jul; 66(7):887-897. PubMed ID: 35348529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Approach to Transverse Colon Cancer: Analysis of Current Practice and Oncological Outcomes Using the National Cancer Database.
    Crippa J; Grass F; Achilli P; Behm KT; Mathis KL; Day CN; Harmsen WS; Mari GM; Larson DW
    Dis Colon Rectum; 2021 Mar; 64(3):284-292. PubMed ID: 33555708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What Is the Optimal Elective Colectomy for Splenic Flexure Cancer: End of the Debate? A Multicenter Study From the GRECCAR Group With a Propensity Score Analysis.
    Manceau G; Alves A; Meillat H; Benhaïm L; Ouaïssi M; Panis YH; Tuech JJ; Dousset B; Brigand C; Cotte E; Lakkis Z; Badic B; Marchal F; Sabbagh C; Diouf M; Karoui M
    Dis Colon Rectum; 2022 Jan; 65(1):55-65. PubMed ID: 34882628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
    You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
    Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Significance of Enlarged Lymph Nodes in Stage II Colorectal Cancer.
    Matsunaga K; Sasaki K; Nozawa H; Kawai K; Murono K; Yamauchi S; Sugihara K; Ishihara S
    Dis Colon Rectum; 2023 Nov; 66(11):e1097-e1106. PubMed ID: 37603828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
    Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer.
    Johnson GGRJ; Robertson RL; Vergis A; Raval M; Phang T; Karimuddin A; Brown C
    Dis Colon Rectum; 2023 Jul; 66(7):1012-1021. PubMed ID: 36876985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer.
    Hagerty BL; Aversa JG; Dominguez DA; Davis JL; Hernandez JM; McCormick JT; Blakely AM
    Dis Colon Rectum; 2022 Oct; 65(10):1206-1214. PubMed ID: 34897212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary Metastasis as the First Site of Metastasis After Curative Surgery for Colon Cancer: Incidence and Risk Factors According to the TNM Stage.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park Y; Shin JK
    Dis Colon Rectum; 2024 Apr; 67(4):523-530. PubMed ID: 38147433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Significance of Preoperative and Postoperative Serum CEA and Carbohydrate Antigen 19-9 Levels in Patients Undergoing Curative Resection of Locally Recurrent Rectal Cancer.
    Paku M; Uemura M; Kitakaze M; Miyoshi N; Takahashi H; Mizushima T; Doki Y; Eguchi H
    Dis Colon Rectum; 2023 Mar; 66(3):392-400. PubMed ID: 36649161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.